# Head-to-head Comparison of [18F]AlF-PSMA-N5 With [18F]F-DCFPyL PET/CT in PCa Diagnosis, Recurrence, and Metastasis

> **NCT06756334** · EARLY_PHASE1 · RECRUITING · sponsor: **Anhui Provincial Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Prostate Cancer
- PET/CT

## Interventions

- **DRUG:** [18F]AlF-PSMA-N5
- **DRUG:** [18F]F-DCFPyL

## Key facts

- **NCT ID:** NCT06756334
- **Lead sponsor:** Anhui Provincial Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-19
- **Primary completion:** 2025-06-30
- **Final completion:** 2025-12-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-01-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06756334

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06756334, "Head-to-head Comparison of [18F]AlF-PSMA-N5 With [18F]F-DCFPyL PET/CT in PCa Diagnosis, Recurrence, and Metastasis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06756334. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*